In an attempt inject a bit of a positive note and to remind us...

In an attempt inject a bit of a positive note and to remind us of the pockets of untapped value that might exist, I continue to explore what additional indications we might wish to pursue. So recently I revisited our US patent filing for some inspiration.

https://patents.google.com/patent/US20210030848A1/en

The abstract probably provides the most likely target list for our next indication/s - I have bolded them below for ease of identification. Now, I am not saying it is likely but for those of you who are keen to see the share price go northward in the near term, who is to say that we might not partner in one or more of these indication in the coming months.

Increased intracranial pressure is observed, for example, in subjects with idiopathic intracranial hypertension (IIH), secondary pseudotumour cerebri, hydrocephalus, normal pressure hydrocephalus, raised intracranial pressure secondary to a brain tumour, meningitis, brain trauma, brain injury, and venous sinus thrombosis.